Gleason Score News and Research

RSS

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States.

11 Mar 2024

Genomic testing rates soar for Black patients with prostate cancer after introduction of precision medicine navigators

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

3 Oct 2023

Predicting bone metastases type in prostate cancer using MRI

Researchers investigated the differences in prostate MRI findings and clinical characteristics between patients with prostate cancer exhibiting bone metastases.

20 Jul 2023

What is the relative burden of oncologic and nononcologic mortality among long-term survivors of cancer in the US?

In a recent study, researchers estimated mortality risk for long-term survivors of cancer.

17 Jul 2023

Enhanced prediction of prostate cancer recurrence using machine learning model

Predicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostatectomy or radiation therapy.

14 Feb 2023

Clinical trial confirms the safety, efficacy of shortened radiation therapy for high-risk prostate cancer patients

A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy.

24 Oct 2022

New model predicts which patients will gain most from PSMA PET scan

A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.

16 Feb 2021

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.

11 Feb 2021

Genetic alterations linked to high incidence of prostate cancer in African American men

Prostate cancer tumors from African American men had higher frequencies of certain genetic alterations that may be associated with aggressive disease, compared with prostate cancer tumors from white men.

28 Oct 2020

New eco-evolutionary mathematical model can predict prostate cancer aggressiveness

Prostate cancer is the most common cancer in men. One in nine men will be diagnosed during their lifetime. While most men will not die from prostate cancer, there is a small subset of patients whose disease is so aggressive at the time of diagnosis that surgery and radiation are not able to control their cancer.

14 May 2020

Study demonstrates accuracy of AI system in diagnosing prostate cancer

The Lancet Oncology has today published the results of a study demonstrating the accuracy of an artificial intelligence system in diagnosing prostate cancer in tissue samples.

10 Jan 2020

New AI system determines aggressiveness of prostate cancer better than most pathologists

Researchers at Radboud university medical center have developed a 'deep learning' system that is better than most pathologists at determining the aggressiveness of prostate cancer. The AI system, which uses tissue samples to arrive at its diagnosis, taught itself to identify prostate cancer based on data from over 1200 patients.

9 Jan 2020

AI identifies previously unknown features relevant to cancer prognosis

Artificial intelligence technology developed by the RIKEN Center for Advanced Intelligence Project in Japan has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.

18 Dec 2019

TSU researchers develop new approach to diagnose adenocarcinoma

Scientists have developed a new approach to the diagnosis of adenocarcinoma - a malignant tumor of the prostate gland. Artificial intelligence is used to determine oncopathology and determine the stage of the disease with this approach.

13 Nov 2019

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the journal Proceedings of the National Academy of Sciences.

27 Aug 2019

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Some 5,400 men are diagnosed with prostate cancer in Finland every year. Although in most cases prostate cancer can be cured, approximately 900 men every year die of it.

30 Jul 2019

Black patients less likely to adopt active surveillance for low-risk prostate cancer than white men

At a time when a growing number of men with prostate cancer considered "low risk" are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less likely than white men to adopt an active surveillance strategy for their disease.

23 May 2019

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Black men diagnosed with prostate cancer classified as low risk may actually have a more-aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.

18 Dec 2018

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

New research on prostate cancer staging shows that PSMA-targeted PET/MRI performs equally as well as currently used predictive tools to determine the risk for advanced disease.

12 Dec 2018

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center estimate that screening for and treating prostate cancer in men aged 70 years or older, which is not recommended by national guidelines, cost Medicare more than $1.2 billion over a three year period for each group of men diagnosed in the United States each year.

14 Sep 2018